The primary endpoint was to demonstrate non-inferiority (with a non-inferiority margin of 0.3%) of tirzepatide 10 mg or 15 mg, or both, compared to glargine in terms of the change in HbA1c from baseline to 52 weeks
Manufactured under strict quality-controlled standards and third-party tested for verification, this advanced growth hormonereleasing peptide combination is trusted by researchers worldwide for its consistency and reliability
Who Should Avoid GHK-Cu Therapy
BPC-157 is a synthetic peptide with potential health benefits, including promoting tissue healing, reducing inflammation, and improving joint health
Formulated with glutathione, a powerful antioxidant, and niacinamide, known for its radiance-enhancing properties, this face cream helps reduce the appearance of dark spots and uneven texture
Claudin-2-deficient mice are defective in the leaky and cation-selective paracellular permeability properties of renal proximal tubules